Megan Garlapow, PhD

Contributing Writer https://www.hematologyadvisor.com

Megan Garlapow, PhD, is the principal and owner of The Line Medical Communications, LLC. Garlapow has worked across a wide variety of projects and therapeutic areas. She holds a BA in biology from the University of Chicago and a PhD in genetics from North Carolina State University. Before working as a medical writer, Garlapow worked in a biopsychology lab, examining social factors affecting breast cancer in rats and people and in a neurogenetics lab, examining the circadian factors affecting nicotine addiction in a mouse model. In her PhD, she used quantitative genetics approaches to examine the regulation of feeding. Her postdoctoral research at Arizona State University focused on environmental and genetic factors affecting body weight. You can find her on LinkedIn at https://www.linkedin.com/in/megangarlapow/

All articles by Megan Garlapow, PhD

Researchers interviewed clinicians and patients to develop a conceptual model of congenital thrombotic thrombocytopenic purpura.

Lymphoma

Nurse Practitioner-Led Rapid Diagnosis Clinic May Reduce Time to Diagnosis in Lymphoma

Megan Garlapow, PhD

November 13, 2019

Patients referred to the clinic were diagnosed nearly 2 weeks faster compared with historical controls.

A premature baby in a bassinet in the hospital.

Bleeding Disorders

Lower Transfusion Threshold for Preterm Neonates With Thrombocytopenia Reduces Risk for Death, Major Bleeds

Megan Garlapow, PhD

November 12, 2019

Patients who were transfused at a lower platelet count threshold experienced a 7% decrease in absolute risk for death or major bleeding.

Leukemia

No Influence of Measurable Residual Disease on Haploidentical Transplantation Outcomes in AML

Megan Garlapow, PhD

November 11, 2019

In patients with complete response at transplant, age was found to be the only predictor of clinical outcomes.

A woman stands on a staircase and checks a fitness tracker on her wrist.

Leukemia

Exercise Intolerance, Neurocognitive Dysfunction in Survivors of Childhood Acute Lymphoblastic Leukemia

Megan Garlapow, PhD

November 8, 2019

Exercise tolerance was found to be associated with verbal fluency, dominant motor speed, and math academics, among other neurocognitive metrics.

Leukemia

Acquired von Willebrand Syndrome in Pediatric Patients With Chronic Myeloid Leukemia

Megan Garlapow, PhD

November 7, 2019

Researchers assessed whether high platelet counts in pediatric patients with chronic myeloid leukemia resulted in thrombosis or bleeding.

A geriatric doctor speaks to an elderly patient.

Thrombotic Disorders

Mental Health Impairment in Acute Thrombotic Thrombocytopenic Purpura

Megan Garlapow, PhD

October 25, 2019

At a median follow-up of 36 months, patients with acute thrombotic thrombocytopenic purpura displayed impaired quality of life compared with the general population.

General Hematology

Discussing Goals of Care With Oncologist, Earlier May Decrease Use of Intensive Health Care at End of Life

Megan Garlapow, PhD

October 25, 2019

Patients with blood cancers were more likely to enroll in hospice earlier if they included a hematologic oncologist in their first discussion about their goals of care.